Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen Completed Phase 3 Trials for Poliomyelitis / Diphtheria / Acellular Pertussis / Tetanus / Viral Hepatitis B / Haemophilus Influenzae Serotype b (Hib) Prevention

Indications	Status	Purpose	Phase
DBCOND0013769 (Poliomyelitis) DBCOND0000394 (Diphtheria) DBCOND0031302 (Acellular Pertussis) DBCOND0000386 (Tetanus) DBCOND0048745 (Viral Hepatitis B) DBCOND0059781 (Haemophilus Influenzae Serotype b (Hib))	Completed	Prevention	3

clinicaltrials.gov Identifier	Title	Drugs
NCT02096263	Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants	Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (DB10788) Bordetella pertussis fimbriae 2/3 antigen (DB10790) Bordetella pertussis pertactin antigen (DB10789) Bordetella pertussis pertactin antigen (formaldehyde inactivated) (DB10992) Bordetella pertussis toxoid antigen (formaldehyde inactivated) (DB14388) Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) (DB10991) Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) (DB10787) Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (DB10584) Haemophilus influenzae b polysaccharide-tetanus conjugate (DB15876) Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen (DB10076) Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen (DB10990) Hepatitis B Vaccine (Recombinant) (DB11627) Poliovirus type 1 antigen (formaldehyde inactivated) (DB10795) Poliovirus type 2 antigen (formaldehyde inactivated) (DB10796) Poliovirus type 3 antigen (formaldehyde inactivated) (DB10797) Rotavirus vaccine (DB10276)